Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
J Obstet Gynaecol Res ; 32(6): 539-44, 2006 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-17100814

RESUMEN

AIM: The efficacy, safety and hospital costs of the tension-free vaginal tape procedure were compared with the pubovaginal sling operation. METHODS: A total of 60 women urodynamically diagnosed as having stress or mixed urinary incontinence were operated on using either the tension-free vaginal tape or pubovaginal sling operation in a prospective manner. Preoperative characteristics of the women were not significantly different for the groups. The women were followed for up to 24 months. RESULTS: In the tension-free vaginal tape group, the operation time was shorter, numbers of analgesics postoperatively required were less and hospital charges were less expensive compared to those in the pubovaginal sling operation (P < 0.01). Kaplan-Meier survival analysis showed a marginal significant difference (P = 0.059) in the objective cumulative cure rates at 24 months between the groups receiving the former (70.3%) and latter (48.3%) procedures. Subjective cure rates were not significantly different (P = 0.101). In both groups, an improvement in quality of life was significant and surgical complications were identical. De novo urge incontinence developed in 6% and 10% in the former and latter, respectively. CONCLUSIONS: The tension-free tape was significantly superior to the pubovaginal sling in terms of operation time, postoperative pain, and hospital charges, but not in cure rates. A longer follow up with a larger sample size is necessary to draw definite conclusions.


Asunto(s)
Procedimientos Quirúrgicos Ginecológicos/métodos , Costos de la Atención en Salud/estadística & datos numéricos , Incontinencia Urinaria de Esfuerzo/cirugía , Procedimientos Quirúrgicos Urológicos/métodos , Anciano , Costos y Análisis de Costo , Femenino , Procedimientos Quirúrgicos Ginecológicos/efectos adversos , Procedimientos Quirúrgicos Ginecológicos/economía , Procedimientos Quirúrgicos Ginecológicos/rehabilitación , Humanos , Estimación de Kaplan-Meier , Persona de Mediana Edad , Estudios Prospectivos , Prevención Secundaria , Mallas Quirúrgicas/efectos adversos , Mallas Quirúrgicas/economía , Análisis de Supervivencia , Resultado del Tratamiento , Procedimientos Quirúrgicos Urológicos/efectos adversos , Procedimientos Quirúrgicos Urológicos/economía , Procedimientos Quirúrgicos Urológicos/rehabilitación
2.
Hinyokika Kiyo ; 52(3): 203-5, 2006 Mar.
Artículo en Japonés | MEDLINE | ID: mdl-16617874

RESUMEN

We report a case of retroperitoneal liposarcoma. A 66-year-old male was referred to our hospital for a retroperitoneal tumor that was detected during gallbladder stone examination. Computed tomography (CT) and magnetic resonance imaging (MRI) revealed an extrarenal lipomatous tumor, 20 x 14 x 8 cm in size, in the right retroperitoneal space. He underwent surgical excision of the tumor with concomitant resection of the right kidney and adrenal gland. The resected tissue weighed 730 g. Histological examination revealed a well differentiated liposarcoma. He received no adjuvant therapy.


Asunto(s)
Liposarcoma/cirugía , Neoplasias Retroperitoneales/cirugía , Adrenalectomía , Anciano , Humanos , Liposarcoma/diagnóstico , Liposarcoma/patología , Imagen por Resonancia Magnética , Masculino , Nefrectomía , Neoplasias Retroperitoneales/diagnóstico , Neoplasias Retroperitoneales/patología , Espacio Retroperitoneal/patología , Tomografía Computarizada por Rayos X
3.
Nihon Hinyokika Gakkai Zasshi ; 95(6): 773-6, 2004 Sep.
Artículo en Japonés | MEDLINE | ID: mdl-15508702

RESUMEN

A 72-year-old man referred our hospital with the chief complaint of macroscopic hematuria. He had undergone simple left nephrectomy for left renal stone when he was 27-years-old. His urine cytology showed class IIIb. They were 4 times. We performed random biopsy of the bladder and retrograde pyelography of the right But they were no positive findings for the cause of hematuria and for the existence of malignancy. After 2 months, he had macroscopic hematuria again. Cystoscopic re-examination revealed a fibrin out of the residual left ureteral orifice. Computed tomographic scan showed a perivesical mass. The diagnosis was the carcinoma of the ureteral stump. We performed ureterectomy. The pathological study revealed the undifferentiated carcinoma. This case is the first report of the undifferentiated carcinoma occurred on the residual ureteral stump in the Japanese literature.


Asunto(s)
Carcinoma/cirugía , Neoplasias Ureterales/cirugía , Anciano , Carcinoma/complicaciones , Carcinoma/diagnóstico , Carcinoma/patología , Hematuria/etiología , Humanos , Cálculos Renales/cirugía , Masculino , Nefrectomía , Uréter/cirugía , Neoplasias Ureterales/complicaciones , Neoplasias Ureterales/diagnóstico , Neoplasias Ureterales/patología
4.
Nihon Hinyokika Gakkai Zasshi ; 95(4): 663-8, 2004 May.
Artículo en Japonés | MEDLINE | ID: mdl-15198000

RESUMEN

OBJECTIVE: The Ministry of Health, Labour and Welfare announced that periconceptional consumption of folic acid will reduce risks of having babies afflicted with Neural Tube Defects (NTDs) in the year of 2000. We assessed awareness of the role of folic acid among urologists and a patient group, how urologists give advices on lifestyle to young women, and what lifestyle the patient group currently maintains. MATERIALS AND METHODS: A postal questionnaire survey was conducted involving 400 urologists randomly selected and a group of 250 female patients afflicted with NTDS and 250 mothers who had given birth to babies having NTDs during the past 7 years. Eighty-four percent of urologists aged 40 years and over and 76% of the patient group aged in their 20s and 30s. Response rates were 56% in the former and 52% in the later. RESULTS: Twenty-six percent of urologists and 92% of the patient group knew an important role folic acid played in prevention of neural tube defects. While 10% of urologists advised to consume multi-vitamins containing folic acid or folic acid supplements, 25% of myelodysplastics and the mothers took them. Sixty-eight percent of doctors advised to take well-balanced food and 82% of the patent group answered that they do. Over 80% of the doctors and the patient group believed that a folic acid campaign is to be organized to inform young women of childbearing age of possible reduction of the risk. CONCLUSION: It is found that proportion of urologists who are aware of a role of periconceptional consumption of folic acid is significantly lower than that of the group of patients (p < 0.0001). Urologists are expected to recognize specific benefits of folic acid in the prevention of NTDs, to advise young women of childbearing age to take well-balanced meals, and to recommend those who wish to be pregnant to consume 400 micrograms of folic acid supplements from 4 weeks before to 12 weeks after conception.


Asunto(s)
Concienciación , Competencia Clínica , Dieta , Ácido Fólico/fisiología , Urología , Adulto , Femenino , Ácido Fólico/administración & dosificación , Ácido Fólico/metabolismo , Humanos , Estilo de Vida , Masculino , Persona de Mediana Edad , Defectos del Tubo Neural/etiología , Defectos del Tubo Neural/metabolismo , Embarazo , Recursos Humanos
5.
Nihon Hinyokika Gakkai Zasshi ; 94(5): 551-9, 2003 Jul.
Artículo en Japonés | MEDLINE | ID: mdl-12910931

RESUMEN

OBJECTIVES: Risk of having fetus affected with neural tube defects can be reduced by maternal periconceptional folic acid supplementation. The purpose of the present study is to investigate how folate is taken from diets and to measure plasma folate concentrations. SUBJECTS AND METHODS: A total of 222 women comprising 5 groups, i.e., healthy women, mothers of myelodysplastic patients, pregnant women, myelodysplastic patients, nurse students, participated in our study. Food frequency questionnaires kept 3 days were analyzed based on the 5th standard table of food composition in Japan. Plasma folate concentrations were measured by means of chemiluminescent immunoassay method. Changes in plasma folate concentrations and possible adverse effects following the folic acid supplementation for 16 weeks were also investigated. RESULTS: The dietary intake of folate, plasma folate concentration and energy intake averaged 293 micrograms/day, 8.1 ng/ml and 1,857 Kcal, respectively, among the subjects. Pregnant women took the largest amount of folate from diets and demonstrated the highest plasma folate concentration among the groups. The dietary folate in myelodysplastic patients and nurse students was significantly lower compared to that of healthy women. The Recommended Dietary Allowance of folate was not fulfilled in 22% of non-pregnant adult women and 72% of pregnant women. The dietary folate was mainly taken from the 3rd food group but the 4th group of food was consumed most. Mean folate intake was significantly correlated with circulating concentrations of serum folate (p = 0.012 r = 0.186). The consecutive administration of 400 micrograms supplements for 16 weeks increased a baseline plasma value of 8.7 ng/ml to 32.6 but fell down rapidly to 17.3 24 hours later without any adverse effects. CONCLUSIONS: The dietary folate and serum folate concentrations averaged 293 micrograms/day and 8.1 ng/ml, respectively. The former is the first report based on the 5th standard table of food composition in Japan. Majority of pregnant women took less dietary folate than what recommended by the government. Those who are capable of becoming pregnant are recommended to consume much of the 3rd food group and those who are planning to become pregnant are recommended to take 400 micrograms of folic acid supplements from 4 weeks before to 12 weeks after conception.


Asunto(s)
Suplementos Dietéticos , Ácido Fólico/administración & dosificación , Ácido Fólico/sangre , Defectos del Tubo Neural , Adolescente , Adulto , Femenino , Alimentos Fortificados , Humanos , Persona de Mediana Edad , Defectos del Tubo Neural/etiología , Necesidades Nutricionales , Embarazo , Riesgo
6.
Nihon Hinyokika Gakkai Zasshi ; 94(5): 574-7, 2003 Jul.
Artículo en Japonés | MEDLINE | ID: mdl-12910934

RESUMEN

We report a patient whose irritable bladder symptoms following Bacillus Calmette Guerin (BCG) instillation were satisfactorily treated by steroid administration. A 59-year-old male had undergone transurethral resection for the bladder carcinoma recurred three times. The histopathological examination revealed the tumor as transitional cell carcinoma, G1 to G2, and pTa. Subsequently an instillation of 80 mg BCG into the bladder was planned 8 times every 7 days. After the 5th instillation he presented with gross hematuria, painful micturition, pollakisuria, urgency and reduced bladder capacity of 15 ml. The dose was reduced to 40 mg and another 3 instillations were accomplished. Since conventional treatments of anti-cholinergics, analgesics and epidural anesthesia were of little help for the subjective symptoms, he was put on the steroid pulse therapy 2 weeks after completion of the BCG regimen. The treatment gradually improved the subjective symptoms and increased the bladder capacity up to 160 ml. In conclusion, we believe that the steroid pulse therapy deserves considering in the early stage of irritable bladder symptoms following BCG instillation.


Asunto(s)
Vacuna BCG/efectos adversos , Carcinoma de Células Transicionales/tratamiento farmacológico , Metilprednisolona/administración & dosificación , Prednisolona/administración & dosificación , Neoplasias de la Vejiga Urinaria/tratamiento farmacológico , Administración Intravesical , Carcinoma de Células Transicionales/patología , Esquema de Medicación , Humanos , Persona de Mediana Edad , Quimioterapia por Pulso , Neoplasias de la Vejiga Urinaria/patología
7.
Nihon Hinyokika Gakkai Zasshi ; 94(1): 15-9, 2003 Jan.
Artículo en Japonés | MEDLINE | ID: mdl-12638200

RESUMEN

OBJECTIVE: To evaluate incidence and treatments of urolithiasis in myelodysplastic patients. PATIENTS AND METHODS: During the past 27 years 303 myelodysplastic patients, 160 men and 143 women, have been treated and 50 of them were operated on with bladder augmentation procedures. Their medical records were retrospectively reviewed. RESULTS: Urolithiasis occurred 20 times in 15 patients, 11 men and 4 women, where calculi developed 18 times in the bladder and twice in the kidney. Prevalence of urolithiasis was 20% (10/50) in those who had undergone bladder augmentation and 2% (5/253) in those who had not had this surgery, where the difference was statistically significant between the two groups (p < 0.01). Overall, 5% of all the patients suffered from stones in the urinary tract. Bladder calculi were endoscopically treated in 11 occasions or were resolved with suprapubic lithotomy in 4 cases. Small stones in the bladder were spontaneously delivered 3 times and extracorporeal shock wave lithotripsy (ESWL) was necessary for a renal calculus in one patient. The last patient having a renal stone has been put under care. Majority of stone compositions consisted of magnesium ammonium phosphate (MAP). CONCLUSION: It was found that urolithiasis was 10 times more prevalent in those patients operated on with enterocystoplasty than those without bladder augmentation and that intermittent clean catheterization and regular bladder irrigation were of necessity to prevent urolithiasis for those having enterocystoplasty.


Asunto(s)
Disrafia Espinal/complicaciones , Cálculos Urinarios/epidemiología , Cálculos Urinarios/terapia , Adolescente , Adulto , Niño , Femenino , Humanos , Litotricia , Masculino , Prevalencia , Estudios Retrospectivos , Vejiga Urinaria/cirugía , Cálculos Urinarios/etiología , Cálculos Urinarios/prevención & control , Procedimientos Quirúrgicos Urológicos/efectos adversos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA